Previous Article |
Table of Contents
| Next Article
Vol. 95, Issue 14, 8274-8279, July 7, 1998
Department of Biochemistry and Biotechnology, University of Kuopio,
P.O.B. 1627, Fin-70211, Kuopio, Finland
Communicated by J. Edwin Seegmiller, University of California, La
Jolla, CA, April 23, 1998 (received for review January 9, 1998)
Calcium phosphate is deposited in many diseases, but formation
mechanisms remain speculative. Nanobacteria are the smallest cell-walled bacteria, only recently discovered in human and cow blood
and commercial cell culture serum. In this study, we identified with
energy-dispersive x-ray microanalysis and chemical analysis that all
growth phases of nanobacteria produce biogenic apatite on their cell
envelope. Fourier transform IR spectroscopy revealed the mineral as
carbonate apatite. The biomineralization in cell culture media resulted
in biofilms and mineral aggregates closely resembling those found in
tissue calcification and kidney stones. In nanobacteria-infected
fibroblasts, electron microscopy revealed intra- and extracellular
acicular crystal deposits, stainable with von Kossa staining and
resembling calcospherules found in pathological calcification. Previous
models for stone formation have led to an hypothesis that elevated pH
due to urease and/or alkaline phosphatase activity is a lithogenic
factor. Our results indicate that carbonate apatite can be formed
without these factors at pH 7.4, at physiological phosphate and calcium
concentrations. Nanobacteria can produce apatite in media mimicking
tissue fluids and glomerular filtrate and provide a unique model for
in vitro studies on calcification.
The formation of discrete and organized inorganic crystalline
structures within macromolecular extracellular matrices is a widespread
biological phenomenon generally referred to as biomineralization. Mammalian bone and dental enamel are examples of biomineralization involving apatite minerals. The molecular basis of mineralization remains largely unknown (1). Recently, bacteria have been implicated as
factors in biogeochemical cycles for mineral formation in aqueous sediments (2, 3). The principal constituent of modern authigenic phosphate minerals in marine sediments is carbonate
(hydroxy)fluorapatite Ca10(PO4)6-x(CO3)x(F,OH)2+x.
Microorganisms are capable of depositing apatite outside thermodynamic
equilibrium in sea water. They can segregate Ca from Mg and actively
nucleate carbonate apatite by means of specific oligopeptides under
conditions pH < 8.5 and [Mg]:[Ca] > 0.1 (4). Such conditions are
also present in the human body.
We have discovered nanobacteria in human and cow blood that are
cytotoxic in vitro (5) and in vivo (6).
They have been deposited in DSM (no. 5819-5821; Braunschweig,
Germany). Nanobacteria possess unusual properties, making their
detection difficult with standard microbiological methods. Although
they typically had diameters of 0.2-0.5 µm, they passed through
0.1-µm filters probably because tiny forms (0.05-0.2 µm) were also
observed in transmission electron microscopy (TEM) (7). Nanobacteria
were poorly disruptable, stainable, fixable, and exceptionally
resistant to heat (8, 9). Their doubling time was about 3 days. High
doses of In this study, we provide evidence that nanobacteria can act as
crystallization centers (nidi) for the formation of biogenic apatite
structures. The mineralization process was studied in vitro with one bovine isolate from commercial fetal bovine
serum (FBS) and with a human isolate. Our findings are of concern in medicine because nanobacterial bacteremia occurs in humans, and nanobacterial nidi might initiate pathological calcification.
Culture Methods for Nanobacteria.
Nanobacteria were cultured
in DMEM (GIBCO) under mammalian cell culture conditions (37°C;
5-10% CO2/90-95% air). Serum was used at a 10% final
concentration as the supplement and source of nanobacteria, which were
FBS ( lot 901045; Sera-Lab, Crawley Down, Sussex, U.K.) or human serum
from a 29-years-old Finnish male, as described previously (5). The
cultures were prepared using strict aseptic techniques in a cell
culture facility. Nanobacterial samples were filtered through 0.2-µm
filters before culturing. Subcultures were made using either the same
serum or
Medical Sciences
Nanobacteria: An alternative mechanism for pathogenic intra- and
extracellular calcification and stone formation
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-irradiation or aminoglycoside antibiotics prevented their
multiplication. According to the 16S rRNA gene sequence (EMBL X98418
and X98419), nanobacteria fall within the
-2 subgroup of
Proteobacteria, which also includes Brucella and
Bartonella species (10). The latter genera include human
and animal pathogens that share similarities with nanobacteria, e.g.,
some antigens (our unpublished data), intra- and extracellular location
in the host, and cytopathic effects (5).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-irradiated FBS (
-FBS) as a culture supplement. FBS and
nanobacteria were
-irradiated, when indicated, at a minimum dose of
30 kGy given at room temperature during about 16 hr (Kolmi-Set,
Ilomantsi, Finland).
-FBS or
-irradiated nanobacteria (10). Neither mineralization nor nanobacteria multiplication was observed even during the 6-mo follow-up.
Preparation and Infection of 3T6 Cells. 3T6 cells (ATCC CCL 96) were cultured on coverslips as described before (5). SF nanobacterial cultures were scraped and 100-µl portions were added to the cell cultures and incubated for 24 hr in the incubator. Only DMEM was added to the control experiments. TEM, IIFS (5), and DNA and von Kossa staining were used for the observation of the cell-SF nanobacteria interaction.
Kidney Stones.
Thirty randomly collected kidney stones (K-SKS;
Stone Analysis Central Laboratory, Jyväskylä, Finland) were
demineralized in 1 M HCl and then neutralized (2), centrifuged at
14,000 × g for 15 min, and the pellets used
for IIFS and TEM. Part of the pellets were suspended in
DMEM, sterile-filtered, and cultured in DMEM supplemented with
-FBS
under nanobacterial culture conditions.
Staining Methods. DNA stainings with Hoechst 33258 fluorochrome were carried out as described in a Hoechst Stain kit (Flow Laboratories), except where indicated, increasing the stain concentration from 0.5 µg/ml to 5 µg/ml (7). IgG1 class anti-nanobacterial mAbs, Nb 8/0 and Nb 5/2, were used in IIFS (5). The epitope of the latter mAb was inactivated by incubating it in sodium borohydrate (3 × 1 min; 0.5 mg/ml in PBS), when indicated, to test specificity of the binding. The samples were viewed under a Nikon Microphot-FXA microscope with fluorescence and differential interference contrast (DIC) optics. Specific calcification detection was performed with von Kossa staining (12). 3T6 cells exposed to SF nanobacteria for 48 hr were used as samples.
Electron Microscopy and Energy Dispersive X-Ray Microanalysis (EDX). For negative staining, nanobacteria were isolated by centrifugation at 40,000 × g for 1 hr directly from FBS diluted 1:5 in PBS. A carbon-coated 400 mesh copper grid was placed on a drop of the suspension of nanobacteria in PBS for 1 min, washed with water, and stained on a drop of 1% phosphotungstic acid for 90 sec. Scanning electron microscopy (SEM) and TEM were performed as described previously (5). The topographic features of the nanobacteria were investigated with a scanning electron microscope equipped with EDX as described previously (13). Hydroxyapatite (No-H-0252; Sigma) was used as a reference.
Fourier Transform IR Spectroscopy (FTIR), Chemical Analysis, and Enzyme Assays. Hydroxyl and carbonate groups in the apatite minerals were detected by FTIR in the K-SKS (Stone Analysis Central Laboratory) following the standard method (14). Chemical analysis of nanobacteria was carried out as described previously (15). Urease enzyme activity was analyzed using the standard method (16) and alkaline phosphatase (AP) with p-nitrophenylphosphate as substrate at pH 9.5.
| |
RESULTS |
|---|
|
|
|---|
Culture Properties, Morphology, and Apatite Formation by Nanobacteria in Serum-Containing Media. Light microscopy with DIC optics revealed barely detectable nanobacteria near the bottom of the culture vessel after about a 1-wk culture period. In 2 wk, nanobacteria appeared as groups easily visible in microscopy. After 1 mo, many were in clumps and started to attach to the bottom of the culture vessel, and by the end of 2 mo, most were in a white-colored biofilm visible to the naked eye. The criteria for pure nanobacterial culture were refractile aggregates of typical coccoid-shaped particles (Fig. 1A), showing DNA stainability (Fig. 1B) only with the modified method, a negative culture result on sheep blood agar, and IIFS positivity with anti-nanobacteria mAbs (5).
|
Apatite Formation by Nanobacteria in Loeffler Medium. Macroscopic nanobacterial colonies on modified Loeffler medium (Fig. 2 A and B) were stony, grayish brown, passagable, and penetrated the medium layer and attached to the bottom of the culture vessel after 6 wk of culture. IIFS with anti-nanobacteria mAbs (data not shown) and TEM revealed nanobacteria coated in needle-like apatite crystals (Fig. 2C) similar to the hydroxyapatite crystals (Fig. 2D).
|
Apatite Formation by Nanobacteria in SF Medium.
When washed
nanobacterial pellets or SF nanobacteria were subcultured in SF DMEM,
bottom-attached coccoid organisms were observed within 1 day. DIC
microscopy revealed a several-micrometer-thick mineral layer around
each nanobacteria, reaching a yeast size within 1 wk (Fig.
3A). Their morphology
differed extensively from the coccoid nanobacteria, but similar DNA
stainability was observed (Fig. 3B). They produced biomass
at about half the rate observed in serum-containing cultures. The
metabolic incorporation of [35S]methionine and
[5-3H]uridine is proof that they were replicating (17).
DIC microscopy revealed nanobacterial multiplication inside the mineral
formations (Fig. 3C). These apatite shelters, were shown in
SEM to have a hollow interiors, were apparently the dwelling place of
the organisms (Fig. 3 E and F). The size of the
cavity is probably dependent on the number of nanobacteria it contains
(Fig. 3F). Apparently, the openings of the cavities were
facing the bottom of the culture vessel before scraping. Thus, the
apatite shelters provided complete protection for the organisms. The
cultures could be passaged monthly for over 5 yr and always followed a
similar growth pattern. After addition of
-FBS, these nanobacterial
formations returned to the forms found in serum cultures (see Fig.
3D). That the shelters were apatite in nature was proven by
EDX. FTIR determined that it was carbonate apatite. The human isolate
produced similar formations.
|
Intra- and Extracellular Calcification in Fibroblast Cultures. 3T6 cells infected for 48 hr with SF nanobacteria showed altered cell morphology, e.g., large vacuolization with internalized SF nanobacteria (Fig. 3G). Control cells were negative (not shown). Standard DNA staining of the nanobacteria-infected cells revealed no ordinary contamination (Fig. 3H). TEM occasionally revealed SF nanobacteria adhering to the cell surface, but mostly they were in various compartments within the cells (Fig. 3 I-L), including nucleus (not shown). von Kossa staining revealed intra- and extracellular calcification in these cells (Fig. 4 D and E). Heavily infected cells showed nuclear abnormalities, e.g., macronucleus, as shown in Fig. 4E, and abnormal nuclear shape (Fig. 3 G, H, K, and L). Control cells were von Kossa negative and did not have nuclear abnormalities (Fig. 4F).
|
Detection of Nanobacterial Antigens in Kidney Stones. We performed a pilot survey on 30 human kidney stones to assess whether nanobacteria can be found. Nanobacteria-specific mAb detecting a protein epitope (5) revealed positive, nanobacteria-sized cocci at various concentrations in all 30 demineralized stones using IIFS. Image of a relevant sample is seen in Fig. 4C. The results could be repeated with another nanobacteria-specific mAb, Nb 5/2, that detects a carbohydrate epitope and the binding could be abolished with sodium borohydrate treatment, which destroys carbohydrate antigens. Specificity was further proven with negative staining results with four different mAbs (IgG1 class) detecting nonrelevant antigens (data not shown). Bacteria of similar size and morphology (Fig. 4B) as nanobacteria (Fig. 4A) were found in strongly positive stones using TEM (Fig. 4 B and C). In nanobacterial culture conditions, sterile-filtered extracts of all of the stones revealed microorganisms having the growth rate, morphology, mineralization, and staining properties of nanobacteria.
| |
DISCUSSION |
|---|
|
|
|---|
We have found nanobacterial culture systems that allow for
reproducible production of apatite calcification in vitro.
Depending on culture conditions, tiny nanocolloid-sized particles
covered with apatite or biofilm, sand, stones, and tumor-like growths of apatite could be produced (Table
1). The
principal precondition for mineralization was low levels of intact
serum in the culture medium. Serum contains powerful proteinaceous
inhibitors of apatite crystal formation, osteopontin, osteocalcin (1),
and fetuin (18), which may account for the observed inhibition and even dissolution of the formed minerals after replenishment of FBS. In cases
of nanobacterial cultures in serum-containing medium, the inhibitors
permitted only marginal mineralization. Mineralization increased in
parallel with the dilution of the serum in cell culture medium.
Finally, in SF medium, apatite formation was extensive and rapid.
Although modified Loeffler medium contains 75% serum, the serum
proteins were denatured during the sterilization steps. Thus, apatite
formation was not inhibited, resulting in solid apatite colonies about
1-5 mm in diameter in 6 wk. Living nanobacteria are needed to produce
apatite in the nanobacterial model.
-Irradiated nanobacteria did not
multiply and, although they could gather apatite on them, no sizable
calcification was produced even after 6-mo incubations.
|
Chemical analysis revealed that the overall composition of biofilm and solid mineral formation was similar to that of bone, except carbonate apatite was formed, as in most extraskeletal tissue calcification and stones, whereas in bone, hydroxyapatite is the prevalent form. Only a few models have been published for studying apatite mineralization in vitro (19-21), e.g.,: (i) Bacterial models of (kidney) stones using bacteria having urease and often AP activity (22, 23). (ii) Osteoblastic cell cultures for studying bone formation. Generally, the apatite formation required elevated Pi and/or Ca2+ levels and AP activity (24). (iii) Gel and other inorganic crystallization models that usually used saturated or supersaturated solutions of Ca2+ and Pi with or without macromolecular components for crystallization (19, 20). In the nanobacterial model, apatite was formed at [Ca] 1.8 mM and [Pi] 0.9 mM or less, without replenishment of the medium.
Nanobacteria may induce calcification and stone formation in vivo because: (i) Nanobacteria have been detected in human blood (10). (ii) Nanobacteria have been shown to be transported from blood into urine as living organisms (6). (iii) Nanobacterial antigens were found in human kidney stones. (iv) Nanobacteria were shown to infect phagocytosing cells (fibroblasts), resulting in intra- and extracellular calcification visible with von Kossa stain and with a similar concentric layer appearance as Michaelis-Gutmann calcospherules found in malacoplakia.
Malacoplakia is a rare chronic inflammatory disease of unknown cause, but a bacterial factor has been implicated. The disease occurs as tumoral growths in urogenital system (bladder, kidney, ureter, and urethra) characterized by an intensive infiltrate of histiocytes containing intra- and extracellular calcospherules composed of apatite. Their size and structure in TEM (25) closely resemble that of our calcified nanobacteria. The possible role of nanobacteria in Michaelis-Gutmann body formation requires further investigation.
Apatite may play a key role in the formation of all kidney stones. The crystalline components of urinary tract stones are calcium oxalate, calcium phosphate, struvite, purines, or cystine. The majority of urinary stones are admixtures of two or more components, with the primary admixture being calcium oxalate and apatite (26). Furthermore, fermentor model studies have shown that calcium phosphate nidi are always formed initially and may subsequently become coated with calcium oxalate or other components (27). SEM reveals the great similarity in size and morphology of SF nanobacteria and human kidney stones (ref. 28; http://www.herringlab.com/sems/sems 2.html) that are formed from small apatite units.
Nanobacteria were found in all 30 human kidney stones that we have screened. In animal experiments, radiolabeled nanobacteria were efficiently excreted from the blood into urine (6). Previously, only struvite stones (4-15% of all kidney stones) composed of magnesium ammonium phosphate and small amounts of apatite have been regarded as deriving from bacteria. They are formed in vitro and probably in vivo by Proteus, staphylococci, and Escherichia coli that produce urease (29), elevating the local pH to more lithogenic levels. AP may augment the lithogenicity. Nanobacteria do not produce urease or AP, but nucleate carbonate apatite directly on their surfaces at pH 7.4, suggesting the presence of nucleating molecules. Since nanobacteria are culturable under physiological conditions in media similar in composition to glomerular filtrate, nanobacteria offer a unique model for kidney stone formation.
Tissue calcification of carbonate apatite in nature is common in other diseases, e.g., atherosclerotic plaques accumulate calcium phosphate. Hemodialysis patients can develop extensive metastatic and tumoral calcification with mechanisms not totally understood (30). Acute periarthritis is apatite arthropathy related to intratendinous calcifications. Apatite crystals are also known to cause inflammation when injected into the synovial space (31). Tissue calcification is found in several malignant diseases (25). Many malignant cells have receptors for nanobacterial adherence (5) that could introduce nanobacteria into the tumor with subsequent calcification, as shown here with von Kossa staining of transformed fibroblasts.
Human and bovine nanobacteria grow similarly, share the same surface antigens and other special features, and both produce carbonate apatite. The possible role of nanobacteria in a variety of pathological calcification conditions is under investigation. In the interim, nanobacteria represent a unique model for evaluating calcification in vitro under physiological conditions.
| |
FOOTNOTES |
|---|
* To whom reprint requests should be addressed. e-mail: Olavi.Kajander{at}uku.fi.
A commentary on this article begins on page 7846.
| |
ABBREVIATIONS |
|---|
AP, alkaline phosphatase;
DIC, differential
interference contrast;
EDX, energy-dispersive x-ray microanalysis;
FBS, fetal bovine serum;
-FBS,
-irradiated FBS;
FTIR, Fourier
transform IR spectroscopy;
IIFS, indirect immunofluorescence staining;
SEM, scanning electron microscopy;
SF, serum free;
SF nanobacteria, nanobacteria cultured under serum-free conditions;
TEM, transmission
electron microscopy.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Robey, P. G. & Boskey, A. L. (1996) in Osteoporosis, eds. Marcus, R., Feldman, D. & Kelsey, J. (Academic, San Diego), pp. 95-183. |
| 2. |
Folk, R. L.
(1993)
J. Sediment. Petrol.
63,
990-999
|
| 3. | Sillitoe, R. H., Folk, R. L. & Saric, N. (1996) Science (Washington DC) 272, 1153-1155 [Abstract]. |
| 4. | Mojzsis, S. J., Arrhenius, G., McKeegan, K. D., Harrison, T. M., Nutman, A. P. & Friend, C. R. L. (1996) Nature (London) 384, 55-59 . |
| 5. | Çiftçioglu, N. & Kajander, E. O. (1998) Pathophysiology 4, 259-270 . |
| 6. | Åkerman, K. K., Kuikka, J. T., Çiftçioglu, N., Parkkinen, J., Bergström, K. A., Kuronen, I. & Kajander, E. O. (1997) SPIE Proc. 3111, 436-442 . |
| 7. | Kajander, E. O., Kuronen, I., Åkerman, K., Pelttari, A. & Çiftçioglu, N. (1997) SPIE Proc. 3111, 420-428 . |
| 8. | Åkerman, K., Kuronen, I. & Kajander, E. O. (1993) Scanning 15, 90-91 . |
| 9. | Kajander, E. O., Tahvanainen, E., Kuronen, I. & Çiftçioglu, N. (1994) Zentralbl. Bakteriol. Suppl. 26, 147-149 . |
| 10. | Çiftçioglu, N., Kuronen, I., Åkerman, K., Hiltunen, E., Laukkanen, J. & Kajander, E. O. (1997) in Vaccines 97, eds. Brown, F., Burton, D., Doherty, P., Mekalanos, J. & Norrby, E. (Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY), pp. 99-103. |
| 11. | Nash, P. & Krenz, M. M. (1991) in Manual of Clinical Microbiology, eds. Balows, A., Hausler, W. J., Jr., Herrmann, K. L., Isenberg, H. D. & Shadomy, H. J. (American Society for Microbiology, Washington, DC), p. 1257. |
| 12. | Luna, L. G. (1968) in Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, ed. Luna, L. G. (McGraw-Hill, New York), pp. 174-188. |
| 13. | Suzuki, T., Yano, M., Sumi, S., Honda, M., Hosoya, Y. & Yoshida, K. I. (1997) Urol. Int. 58, 88-92 [Medline] . |
| 14. | Blijenberg, B. G., van Vliet, M. & Zwang, L. (1997) Eur. J. Clin. Chem. Clin. Biochem. 35, 625-630 [Medline] . |
| 15. | Hyvönen, P. M., Hanhijärvi, H. & Ahosilta, K. (1986) Acta Pharmacol. Toxicol. 59, 129-134 . |
| 16. | Koneman, E. W., Allen, S. D., Janda, W. M., Schreckenberger, P. C. & Winn, C. W., Jr. (1992) Color Atlas and Textbook of Diagnostic Microbiology (Lippincott, Philadelphia), p. 178. |
| 17. | Çiftçioglu, N., Pelttari, A. & Kajander, E. O. (1997) SPIE Proc. 3111, 429-435 . |
| 18. |
Schinke, T., Amendt, C., Trindl, A., Poschke, O., Muller-Esterl, W. & Janhen-Dechent, W.
(1996)
J. Biol. Chem.
271,
20789-2096
|
| 19. | Achilles, W., Jöckel, U., Schaper, A., Burk, M. & Riedmiller, H. (1995) Scanning Micros. 9, 577-586 . |
| 20. | Boskey, A. L. (1989) J. Phys. Chem. 93, 1628-1633 . |
| 21. |
Stanford, C. M., Jacobson, P. A., Eanes, E. D., Lembke, L. A. & Midura, R. J.
(1995)
J. Biol. Chem.
270,
9420-9428
|
| 22. |
McLean, R. J., Nickel, J. C., Noakes, V. C. & Costerton, J. W.
(1985)
Infect. Immun.
49,
805-811
|
| 23. | McLean, R. J., Nickel, J. C., Beveridge, T. J. & Costerton, J. W. (1989) J. Med. Microbiol. 29, 1-7 [Abstract]. |
| 24. | Stanford, C. M., Jacobson, P. A., Eanes, E. D., Lembke, L. A. & Midura, R. J. (1995) J. Biol. Chem. 270, 9420-9428 . |
| 25. | Ho, K. L. (1989) Arch. Pathol. Lab. Med. 113, 874-879 [Medline] . |
| 26. | Mandel, N. (1996) Semin. Nephrol. 16, 364-374 [ISI][Medline] . |
| 27. | Leusmann, D. B. & Sabinski, F. (1996) Urol. Res. 24, 73-78 [Medline] . |
| 28. | Kajander, E. O., Björklund, M. & Çiftçioglu, N. (1998) in Enigmatic Microorganisms and Life in Extreme Environments, ed. Seckcbach, J. (Kluwer, The Netherlands), in press. |
| 29. | Hugosson, J., Grenabo, L., Hedelin, H., Petterson, S. & Seeberg, S. (1990) J. Urol. 143, 965-968 [Medline] . |
| 30. | Zins, B., Zingraff, J., Basile, C., Petitclerc, T., Urena, P., Bardin, T. & Drueke, T. (1992) Nephron 60, 260-267 [Medline] . |
| 31. | Hamada, J. (1995) Nippon Seikeigeka Gakkai Zasshi 69, 1158-1169 [Medline] . |
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
J. Martel and J. D.-E Young From the Cover: Purported nanobacteria in human blood as calcium carbonate nanoparticles PNAS, April 8, 2008; 105(14): 5549 - 5554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bratos-Perez, P. L. Sanchez, S. Garcia de Cruz, E. Villacorta, I. F. Palacios, J. M. Fernandez-Fernandez, S. Di Stefano, A. Orduna-Domingo, Y. Carrascal, P. Mota, et al. Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification Eur. Heart J., February 1, 2008; 29(3): 371 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyoshi, T. Iwatsuki, and T. Naganuma Phylogenetic Characterization of 16S rRNA Gene Clones from Deep-Groundwater Microorganisms That Pass through 0.2-Micrometer-Pore-Size Filters Appl. Envir. Microbiol., February 1, 2005; 71(2): 1084 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Miller, G. Rodgers, J. A. Charlesworth, B. Kirkland, S. R. Severson, T. E. Rasmussen, M. Yagubyan, J. C. Rodgers, F. R. Cockerill III, R. L. Folk, et al. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1115 - H1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, R. J. Katz, A. A. Quyyumi, D. A. Canos, D. Rott, G. Csako, A. Zalles-Ganley, J. Ogunmakinwa, A. G. Wasserman, and S. E. Epstein Association of Serum Antibodies to Heat-Shock Protein 65 With Coronary Calcification Levels: Suggestion of Pathogen-Triggered Autoimmunity in Early Atherosclerosis Circulation, January 6, 2004; 109(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ciftcioglu, D. S. McKay, E. O. Kajander, H.-C. Hung, W. Willett, A. Merchant, B. A. Rosner, A. Ascherio, and K. J. Joshipura Association Between Nanobacteria and Periodontal Disease * Response Circulation, August 26, 2003; 108(8): e58 - 59. [Full Text] [PDF] |
||||
![]() |
K. Aho, E. O. Kajander, and D. Raoult Pitfalls in Detection of Novel Nanoorganisms J. Clin. Microbiol., July 1, 2003; 41(7): 3460 - 3461. [Full Text] [PDF] |
||||
![]() |
K. Benzerara, N. Menguy, F. Guyot, C. Dominici, and P. Gillet Nanobacteria-like calcite single crystals at the surface of the Tataouine meteorite PNAS, June 24, 2003; 100(13): 7438 - 7442. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rodriguez-Navarro, M. Rodriguez-Gallego, K. Ben Chekroun, and M. T. Gonzalez-Munoz Conservation of Ornamental Stone by Myxococcus xanthus-Induced Carbonate Biomineralization Appl. Envir. Microbiol., April 1, 2003; 69(4): 2182 - 2193. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Drancourt, V. Jacomo, H. Lepidi, E. Lechevallier, V. Grisoni, C. Coulange, E. Ragni, C. Alasia, B. Dussol, Y. Berland, et al. Attempted Isolation of Nanobacterium sp. Microorganisms from Upper Urinary Tract Stones J. Clin. Microbiol., January 1, 2003; 41(1): 368 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ciftcioglu, M. A. Miller-Hjelle, J. T. Hjelle, and E. O. Kajander Inhibition of Nanobacteria by Antimicrobial Drugs as Measured by a Modified Microdilution Method Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2077 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
Cutaneous gangrene in a renal dialysis patient Postgrad. Med. J., November 1, 2001; 77(913): 736d - 736. [Full Text] [PDF] |
||||
![]() |
E. B. Breitschwerdt, S. Sontakke, A. Cannedy, S. I. Hancock, and J. M. Bradley Infection with Bartonella weissii and Detection of Nanobacterium Antigens in a North Carolina Beef Herd J. Clin. Microbiol., March 1, 2001; 39(3): 879 - 882. [Abstract] [Full Text] |
||||
![]() |
P. L. Bond, G. K. Druschel, and J. F. Banfield Comparison of Acid Mine Drainage Microbial Communities in Physically and Geochemically Distinct Ecosystems Appl. Envir. Microbiol., November 1, 2000; 66(11): 4962 - 4971. [Abstract] [Full Text] |
||||
![]() |
J. O. Cisar, D.-Q. Xu, J. Thompson, W. Swaim, L. Hu, and D. J. Kopecko An alternative interpretation of nanobacteria-induced biomineralization PNAS, October 10, 2000; 97(21): 11511 - 11515. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brunet and Y. Berland Water quality and complications of haemodialysis Nephrol. Dial. Transplant., May 1, 2000; 15(5): 578 - 580. [Full Text] [PDF] |
||||
![]() |
B. Lorber Are All Diseases Infectious? Another Look Ann Intern Med, December 21, 1999; 131(12): 989 - 990. [Full Text] |
||||
![]() |
Newly Discovered Tiny Bacteria May Cause Kidney Stones Journal Watch (General), August 7, 1998; 1998(807): 2 - 2. [Full Text] |
||||
![]() |
D. A. Carson An infectious origin of extraskeletal calcification PNAS, July 7, 1998; 95(14): 7846 - 7847. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||